Peer-influenced content. Sources you trust. No registration required. This is HCN.
Annals of Internal Medicine
A two-year analysis of 12,670 screened men found that the Stockholm3 risk model detected more clinically significant prostate cancers than PSA testing alone, primarily through fewer false-negative results. The findings suggest improved screening discrimination, although follow-up remains limited to two years.
Oncology, Medical July 29th 2026